• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

一种水稳定的红色发光自由基阳离子用于突变型 p53 癌症治疗。

A Water-Stable and Red-Emissive Radical Cation for Mutp53 Cancer Therapy.

机构信息

National Engineering Research Center for Tissue Restoration and Reconstruction, Key Laboratory of Biomedical Engineering of Guangdong Province, Key Laboratory of Biomedical Materials and Engineering of the Ministry of Education, Innovation Center for Tissue Restoration and Reconstruction, School of Biomedical Science and Engineering, School of Medicine, School of Materials Science and Engineering, South China University of Technology, Guangzhou, 510006, China.

Institute of Marine Drugs, Guangxi University of Chinese Medicine, Nanning, 530200, China.

出版信息

Angew Chem Int Ed Engl. 2022 Nov 14;61(46):e202212671. doi: 10.1002/anie.202212671. Epub 2022 Oct 17.

DOI:10.1002/anie.202212671
PMID:36149752
Abstract

Compared with conventional closed-shell fluorophores, radical cations provide an opportunity for development of red-to-NIR fluorophores with small sizes and easy preparation. However, most radical cations reported in the literature suffer from poor stability in water solution and are almost non-emissive. To tackle this challenge, we herein develop a deep-red-emissive and water-stable pyrrole radical cation P⋅ -DPA-Zn, which can be easily generated from P-DPA-Zn by air oxidation. The deep-red-emissive P⋅ -DPA-Zn can be used for imaging-guided mitochondria-targeted delivery of Zn into cancer cells to promote mutant p53 proteins degradation and abrogate mutp53-manifested gain of function, including reduced chemotherapy resistance, inhibited cancer cell migration, decreased tumor cell colony and sphere formation. The water-stable and deep-red emissive pyrrole radical cation is thus promising for cancer theranostic applications.

摘要

与传统的闭壳层荧光团相比,自由基阳离子为开发小尺寸、易于制备的近红外荧光团提供了机会。然而,文献中报道的大多数自由基阳离子在水溶液中稳定性差,几乎没有发光。为了解决这一挑战,我们开发了一种深红光发射、水溶性的吡咯自由基阳离子 P⋅-DPA-Zn,它可以很容易地通过空气氧化从 P-DPA-Zn 中产生。深红光发射的 P⋅-DPA-Zn 可用于成像引导的线粒体靶向递锌进入癌细胞,以促进突变型 p53 蛋白的降解并消除 mutp53 表现出的功能获得,包括降低化疗耐药性、抑制癌细胞迁移、减少肿瘤细胞集落和球体形成。因此,这种水溶性、深红光发射的吡咯自由基阳离子有望用于癌症的治疗诊断应用。

相似文献

1
A Water-Stable and Red-Emissive Radical Cation for Mutp53 Cancer Therapy.一种水稳定的红色发光自由基阳离子用于突变型 p53 癌症治疗。
Angew Chem Int Ed Engl. 2022 Nov 14;61(46):e202212671. doi: 10.1002/anie.202212671. Epub 2022 Oct 17.
2
Red-to-NIR emissive radical cations derived from simple pyrroles.源自简单吡咯的红色至近红外发射自由基阳离子。
Mater Horiz. 2021 Nov 1;8(11):3082-3087. doi: 10.1039/d1mh01121a.
3
In Situ Generation of Red-to-NIR Emissive Radical Cations in the Stomach for Gastrointestinal Imaging.用于胃肠道成像的胃内原位生成从红色到近红外发射的自由基阳离子
Adv Mater. 2023 Apr;35(15):e2209940. doi: 10.1002/adma.202209940. Epub 2023 Mar 4.
4
SAHA shows preferential cytotoxicity in mutant p53 cancer cells by destabilizing mutant p53 through inhibition of the HDAC6-Hsp90 chaperone axis.SAHA 通过抑制 HDAC6-Hsp90 伴侣轴使突变型 p53 失稳,从而对突变型 p53 癌症细胞表现出优先的细胞毒性。
Cell Death Differ. 2011 Dec;18(12):1904-13. doi: 10.1038/cdd.2011.71. Epub 2011 Jun 3.
5
Supramolecular pyrrole radical cations for bacterial theranostics.用于细菌治疗学的超分子吡咯自由基阳离子。
Biomater Sci. 2023 Dec 19;12(1):199-205. doi: 10.1039/d3bm01472j.
6
The PI3K/mTOR dual inhibitor NVP-BEZ235 stimulates mutant p53 degradation to exert anti-tumor effects on triple-negative breast cancer cells.PI3K/mTOR 双重抑制剂 NVP-BEZ235 通过刺激突变型 p53 降解发挥抗肿瘤作用,对三阴性乳腺癌细胞有效。
FEBS Open Bio. 2020 Apr;10(4):535-545. doi: 10.1002/2211-5463.12806. Epub 2020 Mar 6.
7
Glutathionylation-dependent proteasomal degradation of wide-spectrum mutant p53 proteins by engineered zeolitic imidazolate framework-8.工程沸石咪唑酯骨架-8 通过谷胱甘肽化依赖的泛突变 p53 蛋白的蛋白酶体降解
Biomaterials. 2021 Apr;271:120720. doi: 10.1016/j.biomaterials.2021.120720. Epub 2021 Feb 14.
8
The activating transcription factor 3 protein suppresses the oncogenic function of mutant p53 proteins.激活转录因子 3 蛋白抑制突变型 p53 蛋白的致癌功能。
J Biol Chem. 2014 Mar 28;289(13):8947-59. doi: 10.1074/jbc.M113.503755. Epub 2014 Feb 19.
9
DNAJA1 promotes cancer metastasis through interaction with mutant p53.DNAJA1 通过与突变型 p53 相互作用促进癌症转移。
Oncogene. 2021 Aug;40(31):5013-5025. doi: 10.1038/s41388-021-01921-3. Epub 2021 Jun 28.
10
Allele-specific silencing of mutant p53 attenuates dominant-negative and gain-of-function activities.突变型p53的等位基因特异性沉默可减弱显性负性和功能获得性活性。
Oncotarget. 2016 Feb 2;7(5):5401-15. doi: 10.18632/oncotarget.6634.

引用本文的文献

1
Efficacy analysis of targeted P53 therapy in solid tumors.实体瘤中靶向P53治疗的疗效分析
Med Oncol. 2025 Jul 22;42(8):360. doi: 10.1007/s12032-025-02930-y.
2
Discovery of Drugs Targeting Mutant p53 and Progress in Nano-Enabled Therapeutic Strategy for p53-Mutated Cancers.靶向突变型p53的药物发现及p53突变型癌症的纳米治疗策略进展
Biomolecules. 2025 May 26;15(6):763. doi: 10.3390/biom15060763.